Differences in the transient kinetics of the binding of D-ADP and its mirror image L-ADP to human 3-phosphoglycerate kinase revealed by the presence of 3-phosphoglycerate

Biochemistry

Volumn 47, Issue 11, 2008, Pages 3462-3473

  Gondeau, Claire ^a   Chaloin, Laurent ^a   Varga, Andrea ^b   Roy, Béatrice ^c   Lallemand, Perrine ^a   Périgaud, Christian ^c   Barman, Tom ^a   Vas, Mária ^b   Lionne, Corinne ^a  

^a University of Montpellier I and II   (France)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; COMPLEXATION; FLUORESCENCE; IMAGE PROCESSING; METHANOL;

ANTICANCER AGENTS; DISSOCIATION CONSTANTS; NUCLEOSIDE DIPHOSPHATE (NDP); TRANSIENT KINETICS;

ENZYMES;

ADENOSINE DIPHOSPHATE; BUFFER; METHANOL; NUCLEOTIDE; PHOSPHATE; PHOSPHOGLYCERATE KINASE;

ARTICLE; CATALYSIS; CITRIC ACID CYCLE; COMPLEX FORMATION; DISSOCIATION; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME KINETICS; ENZYME MECHANISM; EXPERIMENTATION; FLOW KINETICS; FLUORESCENCE; HUMAN; KINETICS; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; BINDING SITES; BUFFERS; CATALYSIS; COLD; GLYCERIC ACIDS; HUMANS; KINETICS; METHANOL; MODELS, MOLECULAR; PHOSPHOGLYCERATE KINASE; STEREOISOMERISM;

EID: 40849140841     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi7023145     Document Type: Article

References (49)

1. De Clercq, E. (2005) Emerging anti-HIV drugs. Expert Opin. Emerg. Drugs 10, 241-273.
2. De Clercq, E. (2005) Recent highlights in the development of new antiviral drugs. Curr. Opin. Microbiol. 8, 552-560.
3. De Clercq, E. (2005) Antiviral drug discovery and development: where chemistry meets with biomedicine. Antiviral Res. 67, 56-75.
4. Schlichting, I., and Reinstein, J. (1997) Structures of active conformations of UMP kinase from Dictyostelium discoideum suggest phosphoryl transfer is associative. Biochemistry 36, 9290-9296.
5. Alexandre, J. A., Roy, B., Topalis, D., Pochet, S., Périgaud, C., and Deville-Bonne, D. (2007) Enantioselectivity of human AMP, dTMP and UMP-CMP kinases. Nucleic Acids Res. 35, 4895-4904.
6. Scopes, R. K. (1973) 3-Phosphoglycerate kinase. Enzymes (3rd ed.) 8, 335-351.
7. João, H. C., and Williams, R. J. (1993) The anatomy of a kinase and the control of phosphate transfer. Eur. J. Biochem. 216, 1-18.
8. Mathé, C., and Gosselin, G. (2006) L-nucleoside enantiomers as antivirals drugs: a mini-review. Antiviral Res. 71, 276-281.
9. Coates, J. A., Cammack, N., Jenkinson, H. J., Mutton, I. M., Pearson, B. A., Storer, R., Cameron, J. M., and Penn, C. R. (1992) The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Antimicrob. Agents Chemother. 36, 202-205.
10. Schinazi, R. F., Chu, C. K., Peck, A., McMillan, A., Mathis, R., Cannon, D., Jeong, L. S., Beach, J. W., Choi, W. B., Yeola, S., and Liotta, D. C. (1992) Activities of the four optical isomers of 2′,3′-dideoxy-3′- thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes. Antimicrob. Agents Chemother. 36, 672-676.
11. Sabini, E., Hazra, S., Konrad, M., Burley, S. K., and Lavie, A. (2007) Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase. Nucleic Acids Res. 35, 186-192.
12. Verri, A., Montecucco, A., Gosselin, G., Boudou, V., Imbach, J. L., Spadari, S., and Focher, F. (1999) L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity? Biochem. J. 337, 585-590.
13. Blake, C. C., and Evans, P. R. (1974) Structure of horse muscle phosphoglycerate kinase. Some results on the chain conformation, substrate binding and evolution of the molecule from a 3 angstrom Fourier map. J. Mol. Biol. 84, 585-601.
14. Banks, R. D., Blake, C. C. F., Evans, P. R., Haser, R., Rice, D. W., Hardy, G. W., Merrett, M., and Phillips, A. W. (1979) Sequence, structure and activity of phosphoglycerate kinase: a possible hinge-bending enzyme. Nature 279, 773-777.
15. Harlos, K., Vas, M., and Blake, C. C. F. (1992) Crystal structure of the binary complex of pig muscle phosphoglycerate kinase and its substrate 3-phospho-D-glycerate. Proteins 12, 133-144.
16. Flachner, B., Kovári, Z., Varga, A., Gugolya, Z., Vonderviszt, F., Náray-Szabó, G., and Vas, M. (2004) Role of phosphate chain mobility of MgATP in completing the 3-phosphoglycerate kinase catalytic site: Binding, kinetic, and crystallographic studies with ATP and MgATP. Biochemistry 43, 3436-3449.
17. May, A., Vas, M., Harlos, K., and Blake, C. (1996) 2.0 Å resolution structure of a ternary complex of pig muscle phosphoglycerate kinase containing 3-phospho-D-glycerate and the nucleotide Mn adenylylimidodiphosphate. Proteins 24, 292-303.
18. Szilágyi, A. N., Ghosh, M., Garman, E., and Vas, M. (2001) A 1.8 Å resolution structure of pig muscle 3-phosphoglycerate kinase with bound MgADP and 3-phosphoglycerate in open conformation: new insight into the role of the nucleotide in domain closure. J. Mol. Biol. 306, 499-511.
19. Kovári, Z., Flachner, B., Naray-Szabó, G., and Vas, M. (2002) Crystallographic and thiol-reactivity studies on the complex of pig muscle phosphoglycerate kinase with ATP analogues: correlation between nucleotide binding mode and helix flexibility. Biochemistry 41, 8796-8806.
20. Kovári, Z., and Vas, M. (2004) Protein conformer selection by sequence-dependent packing contacts in crystals of 3-phosphoglycerate kinase. Proteins 55, 198-209.
21. Bernstein, B. E., Michels, P. A. M., and Hol, W. G. J. (1997) Synergistic effects of substrate-induced conformational changes in phosphoglycerate kinase activation. Nature 385, 275-278.
22. Auerbach, G., Huber, R., Grattinger, M., Zaiss, K., Schurig, H., Jaenicke, R., and Jacob, U. (1997) Closed structure of phosphoglycerate kinase from Thermotoga maritima reveals the catalytic mechanism and determinants of thermal stability. Structure 5, 1475-1483.
23. Gallois-Montbrun, S., Faraj, A., Seclaman, E., Sommadossi, J. P., Deville-Bonne, D., and Véron, M. (2004) Broad specificity of human phosphoglycerate kinase for antiviral nucleoside analogs. Biochem. Pharmacol. 68, 1749-1756.
24. Krishnan, P., Gullen, E. A., Lam, W., Dutschman, G. E., Grill, S. P., and Cheng, Y. C. (2003) Novel role of 3-phosphoglycerate kinase, a glycolytic enzyme, in the activation of L-nucleoside analogs, a new class of anticancer and antiviral agents. J. Biol. Chem. 278, 36726-36732.
25. Varga, A., Szabó, J., Flachner, B., Roy, B., Konarev, P., Svergun, D., Závodszky, P., Périgaud, C., Barman, T., Lionne, C., and Vas, M. (2008) Interaction of human 3-phosphoglycerate kinase with L-ADP, the mirror image of D-ADP. Biochem. Biophys. Res. Commun. 366, 994-1000.
26. Vas, M., Merli, A., and Rossi, G. L. (1994) Antagonistic binding of substrates to 3-phosphoglycerate kinase monitored by the fluorescent analogue 2′(3′)-O-(2,4,6 trinitrophenyl)adenosine 5′-triphosphate. Biochem. J. 301, 885-891.
27. Merli, A., Szilágyi, A. N., Flachner, B., Rossi, G. L., and Vas, M. (2002) Nucleotide binding to pig muscle 3-phosphoglycerate kinase in the crystal and in solution: Relationship between substrate antagonism and interdomain communication. Biochemistry 41, 111-119.
28. Varga, A., Flachner, B., Gráczer, E., Osváth, S., Szilágyi, A. N., and Vas, M. (2005) Correlation between conformational stability of the ternary enzyme-substrate complex and domain closure of 3-phosphoglycerate kinase. FEBS J. 272, 1867-1885.
29. Varga, A., Flachner, B., Konarev, P., Gráczer, É., Szabó, J., Svergun, D., Závodszky, P., and Vas, M. (2006) Substrate-induced double sided H-bond network as a means of domain closure in 3-phosphoglycerate kinase. FEBS Lett. 580, 2698-2706.
30. Geerlof, A., Schmidt, P. P., Travers, F., and Barman, T. (1997) Cryoenzymic studies on yeast 3-phosphoglycerate kinase. Attempt to obtain the kinetics of the hinge-bending motion. Biochemistry 36, 5538-5545.
31. Geerlof, A., Travers, F., Barman, T., and Lionne, C. (2005) Perturbation of yeast 3-phosphoglycerate kinase reaction mixtures with ADP: transient kinetics of formation of ATP from bound 1,3-bisphosphoglycerate. Biochemistry 44, 14948-14955.
32. He, J., Roy, B., Périgaud, C., Kashlan, O. B., and Cooperman, B. S. (2005) The enantioselectivities of the active and allosteric sites of mammalian ribonucleotide reductase. FEBS J. 272, 1236-1242.
33. Schmidt, P. P., Travers, F., and Barman, T. (1995) Transient and equilibrium kinetic studies on yeast 3-phosphoglycerate kinase. Evidence that an intermediate containing 1,3-bisphosphoglycerate accumulates in the steady state. Biochemistry 34, 824-832.
34. Sali, A., and Blundell, T. L. (1993) Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815.
35. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: visual molecular dynamics. J. Mol. Graph. 14, 33-38.
36. Davies, G. J., Gamblin, S. J., Littlechild, J. A., Dauter, Z., Wilson, K. S., and Watson, H. C. (1994) Structure of the ADP complex of the 3-phosphoglycerate kinase from Bacillus stearothermophilus at 1.65 Å. Acta Crystallogr. D50, 202-209.
37. Brooks, B., Bruccoleri, R., Olafson, B., States, D. S. S., and Karplus, M. (1983) CHARMM: a program for macromolecular energy, minimization and molecular dynamics calculations. J. Comput. Chem. 4, 187-217.
38. Scopes, R. K. (1978) Binding of substrates and other anions to yeast phosphoglycerate kinase. Eur. J. Biochem. 91, 119-129.
39. Johnson, P. E., Abbott, S. J., Orr, G. A., Sémériva, M., and Knowles, J. R. (1976) The "phosphoryl-enzyme" from phosphoglycerate kinase. Biochemistry 15, 2893-2901.
40. Douzou, P. (1977) Enzymology at subzero temperatures. Adv. Enzymol. Relat. Areas Mol. Biol. 45, 157-272.
41. Gutfreund, H. (1995) Kinetics for the Life Sciences, Cambridge University Press, Cambridge.
42. Koshland, D. E., Jr (1956) Molecular geometry in enzyme action. J. Cell. Physiol. Suppl. 47, 217-234.
43. Gutfreund, H. (1987) Reflections on the kinetics of substrate binding. Biophys. Chem. 26, 117-121.
44. Cserpán, I., and Vas, M. (1983) Effects of substrates on the heat stability and on the reactivities of thiol groups of 3-phosphoglycerate kinase. Eur. J. Biochem. 131, 157-162.
45. Vas, M., and Batke, J. (1984) Adenine nucleotides affect the binding of 3-phosphoglycerate to pig muscle 3-phosphoglycerate kinase. Eur. J. Biochem. 139, 115-123.
46. Deville-Bonne, D., Laine, R., and Garel, J. R. (1991) Substrate antagonism in the kinetic mechanism of E. coli phosphofructokinase-1. FEBS Lett. 290, 173-176.
47. Zheng, R. L., and Kemp, R. G. (1992) The mechanism of ATP inhibition of wild type and mutant phosphofructo-1-kinase from Escherichia coli. J. Biol. Chem. 267, 23640-23645.
48. Viola, R. E., Raushel, F. M., Rendina, A. R., and Cleland, W. W. (1982) Substrate synergism and the kinetic mechanism of yeast hexokinase. Biochemistry 21, 1295-1302.
49. Sabini, E., Hazra, S., Konrad, M., and Lavie, A. (2007) Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides. J. Med. Chem. 50, 3004-3014.